首页> 外文期刊>TMR Modern Herbal Medicine >Mangiferin ameliorates hyperglycemia by inhibiting oxidation and α-glucosidase activity
【24h】

Mangiferin ameliorates hyperglycemia by inhibiting oxidation and α-glucosidase activity

机译:芒果苷通过抑制氧化和α-葡萄糖苷酶活性改善高血糖

获取原文
       

摘要

Objective Mangiferin (MF) is a polyphenol isolated from the root of AnemarrhenaasphodeloidesBge.. This study was aimed to investigate the effects of MF on hyperglycemia in animal models of insulin resistance and streptozotocin (STZ)-induced diabetes. Methods The diabetes mellitus model was established in mice by receiving a multiple hypodermic injection of hydrocortisone sodium succinate (HCSS) (70 mg/kg) or a single intravenous injection of STZ (130 mg/kg). Meanwhile MF at different dosage (50, 100 and 200 mg/kg) were oral administrated for consecutive 10 days. Data of blood glucose were collected at different time after intraperitoneal injection of insulin (0.5 U/kg) to investigate the insulin resistant. As well as the oxygen radical absorbance capacity (ORAC) and superoxide dismutase (SOD) activity of kidney were measured. The in vitro experiment was established to investigate the inhibitory capacity of MF to α-glucosidase.Results Oral administration of MF significantly prevented insulin resistance caused by HCSS injection. STZ-induced diabetic symptoms were also improved, including fasting blood glucose, glycated hemoglobin, plasma triglycerides, hepatic glycogen, kidney SOD and ORAC level. The in vitro experiment demonstrated that MF had potent α-glucosidase inhibitory activity. Conclusion The obtained results demonstrate that MF ameliorates insulin resistance and STZ-induced glucose metabolism disturbance. The MF exerts the protective effects through improving the antioxidant ability, promoting hepatic glycogen synthesis and inhibiting α-glucosidase activity. Highlights Mangiferin (MF), a polyphenol extracted from the root of AnemarrhenaasphodeloidesBge., significantly ameliorates insulin resistance and streptozotocin (STZ)-induced diabetic symptoms. Potential mechanisms were involved in improving the antioxidant ability and inhibiting α-glucosidase activity. This study provides corresponding evidence for the clinical application of mangiferin.
机译:目的芒果苷(MF)是一种从知母(AnemarrhenaasphodeloidesBge)根中分离出来的多酚。本研究旨在研究MF对胰岛素抵抗和链脲佐菌素(STZ)诱导的糖尿病动物模型中高血糖的影响。方法通过多次皮下注射氢化可的松琥珀酸钠(HCSS)(70 mg / kg)或单次静脉注射STZ(130 mg / kg),在小鼠中建立糖尿病模型。同时,连续10天口服不同剂量的MF(50、100和200 mg / kg)。腹膜内注射胰岛素(0.5 U / kg)后的不同时间收集血糖数据,以研究胰岛素抵抗。还测量了肾脏的氧自由基吸收能力(ORAC)和超氧化物歧化酶(SOD)活性。建立了体外实验,研究了MF对α-葡萄糖苷酶的抑制能力。结果口服MF可明显预防HCSS注射引起的胰岛素抵抗。 STZ诱导的糖尿病症状也得到改善,包括空腹血糖,糖化血红蛋白,血浆甘油三酸酯,肝糖原,肾脏SOD和ORAC水平。体外实验表明,MF具有强力的α-葡萄糖苷酶抑制活性。结论所得结果表明,MF改善了胰岛素抵抗和STZ诱导的葡萄糖代谢紊乱。 MF通过提高抗氧化能力,促进肝糖原合成和抑制α-葡萄糖苷酶活性发挥保护作用。亮点Mangiferin(MF)是从知母(AnemarrhenaasphodeloidesBge。)根中提取的多酚,可显着改善胰岛素抵抗和链脲佐菌素(STZ)诱导的糖尿病症状。潜在的机制与提高抗氧化能力和抑制α-葡萄糖苷酶活性有关。该研究为芒果苷的临床应用提供了相应的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号